Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Consensus
Buy3.67 / 5
9 ratings · Buy 6 · Hold 3
Price vs analyst targets
Revenue and EPS estimates
Reported
Consensus estimates
Fiscal period
FY2023Dec '23
FY2024Dec '24
FY2025Dec '25
FY2026Dec '26
FY2027Dec '27
FY2028Dec '28
FY2029Dec '29
FY2030Dec '30
Revenue (M)
0.2
0.0
0.0
4.7
12.9
79.3
350.5
667.8
Growth YoY
−34.2%
−85.1%
−93.0%
+280243.9%
+176.4%
+514.1%
+341.8%
+90.5%
High estimate
–
0.0
0.0
4.7
12.9
81.7
350.5
667.8
Low estimate
–
0.0
0.0
4.7
12.9
76.9
350.5
667.8
Analysts
–
11
8
7
7
9
4
4
EPS, adjusted
−2.01
−1.25
−0.87
−0.60
−0.64
−0.57
−0.04
0.70
Growth YoY
n/m
n/m
n/m
n/m
n/m
n/m
n/m
n/m
High estimate
–
–
–
−0.56
−0.43
−0.21
−0.04
0.70
Low estimate
–
–
–
−0.62
−0.79
−0.82
−0.04
0.70
Analysts
–
–
–
7
6
10
4
4
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
Brokers
9 firms active in the last 12 months
Firm
Analyst
Rating
Prev rating
Target
Prev target
Chg
Upside
Date
Citizens
–
Market Outperform
Market Outperform
–
–
–
–
Aug 17
HC Wainwright & Co.
–
Buy
Buy
–
–
–
–
Apr 16
JP Morgan
–
Neutral
Underweight
–
–
–
–
Apr 16
Jefferies
–
Buy
Buy
–
–
–
–
Apr 15
Argus Research
–
Market Perform
Market Perform
–
–
–
–
Apr 14
Bernstein
–
Market Perform
Market Perform
$3.85
–
–
+392%
Apr 14
Robert W. Baird
–
Outperform
Outperform
$9.00
$11.00
−18%
+1049%
Apr 14
Canaccord Genuity
–
Buy
Buy
–
–
–
–
Mar 13
Piper Sandler
–
Overweight
Overweight
–
–
–
–
Mar 13
Latest analyst action · Page refreshed hourly; analyst feeds refreshed daily · About this data